The oral glucose tolerance test, usually called the OGTT, is a diagnostic procedure in which you drink a standardized glucose solution on an empty stomach and have your blood drawn at timed intervals to measure how efficiently your body clears sugar from the bloodstream. Since the World Health Organization standardized it in 1980 around a 75-gram glucose load, it has remained the reference method for diagnosing type 2 diabetes and prediabetes, and it plays a central role in screening for gestational diabetes during pregnancy.1PubMed Central. The Oral Glucose Tolerance Test: 100 Years Later Despite being over a century old in concept, the OGTT reveals information about insulin secretion, insulin resistance, and gut hormone responses that simpler blood tests still cannot fully capture.
What Happens During the Test
The standard OGTT begins with an overnight fast of 10 to 16 hours, during which you can drink water but nothing else. At the clinic or lab, a fasting blood sample is drawn first. You then drink 75 grams of glucose dissolved in water, and additional blood samples are taken at set time points, most commonly at 30, 60, 90, and 120 minutes, though the minimum for a diagnostic reading is the fasting and 2-hour draws. The entire visit typically lasts about two and a half hours. You sit quietly during the test; exercise or smoking can skew the results.
What makes the OGTT more informative than a simple fasting blood draw is that it forces the body to respond to a real metabolic challenge. When glucose floods the gut, the pancreas must ramp up insulin production, and gut hormones called incretins, particularly GLP-1 and GIP, amplify that insulin response. In people progressing toward diabetes, one of the earliest detectable breakdowns is a sluggish early insulin response in the first 30 minutes after the glucose load, even when fasting levels still look normal.2PubMed. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance A fasting glucose test simply cannot see that early secretion defect because it never provokes the system.
How to Read the Results
The key number is the 2-hour plasma glucose value. A reading below 140 mg/dL (7.8 mmol/L) is considered normal. A reading between 140 and 199 mg/dL (7.8 to 11.1 mmol/L) is classified as impaired glucose tolerance, the formal term for prediabetes by this test. A reading of 200 mg/dL (11.1 mmol/L) or higher meets the diagnostic threshold for diabetes.3PubMed. Glucose tolerance test – non-pregnant Fasting glucose is also evaluated: below 100 mg/dL is normal, 100 to 125 mg/dL is impaired fasting glucose, and 126 mg/dL or above suggests diabetes.
These categories matter because they carry different risk profiles. People with impaired glucose tolerance have measurably lower insulin sensitivity and weaker early-phase insulin secretion compared with those who test normal, even when body weight is similar between groups.4PubMed. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance Research in Asian populations with prediabetes has found that insulin sensitivity is roughly 15% lower and the acute insulin response to a glucose challenge is about 35% lower than in people with normal glucose tolerance.5PubMed. Dynamic assessment of insulin secretion and insulin resistance in Asians with prediabetes Catching that intermediate state is the primary clinical reason the OGTT exists: it identifies people whose fasting glucose may still be passable but whose metabolic machinery is already struggling under load.
Why HbA1c Does Not Always Replace It
HbA1c, which reflects average blood sugar over the preceding two to three months, is more convenient than the OGTT because it requires no fasting and no two-hour wait. Many clinicians use it as a first-line screen. The trade-off is sensitivity: HbA1c misses a meaningful share of people the OGTT would catch. A meta-analysis in African populations found that HbA1c at the standard diagnostic cutoff picked up only about 58% of diabetes cases identified by the OGTT.6PubMed. The diagnostic accuracy of HbA(1c), compared to the oral glucose tolerance test, for screening for type 2 diabetes mellitus in Africa-A systematic review and meta-analysis A similar meta-analysis in Chinese adults reported that the standard HbA1c threshold would have missed nearly half of newly diagnosed cases.7PubMed. Diagnostic accuracy of glycated hemoglobin compared with oral glucose tolerance test for diagnosing diabetes mellitus in Chinese adults: a meta-analysis
Concordance between HbA1c and OGTT for prediabetes is also surprisingly low. In a study of overweight and obese adults, HbA1c flagged about 40% of participants as prediabetic while the OGTT flagged roughly 20%, and the two tests agreed on a diagnosis only about 60% of the time.8PubMed. Low concordance between HbA1c and OGTT to diagnose prediabetes and diabetes in overweight or obesity The disagreement is not random noise; the tests measure genuinely different things. HbA1c reflects a glucose average, while the OGTT captures peak excursion and the body’s dynamic response to a bolus of sugar. People with normal averages can still spike high after meals, and the OGTT is the test that catches that pattern.
The One-Hour Glucose Value
An area of growing interest is the glucose reading taken at the 60-minute mark, which is not currently part of the standard diagnostic criteria but outperforms both fasting glucose and the traditional 2-hour value in predicting who will go on to develop type 2 diabetes. In a study evaluating multiple time points, the 1-hour plasma glucose had the best predictive accuracy for future diabetes, with stronger sensitivity and a better balance of sensitivity and specificity than the 2-hour reading.9The Journal of Clinical Endocrinology & Metabolism. 1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers
The 1-hour value is not just a better predictor of glucose levels going sideways. A 30-year follow-up study found that people with elevated 1-hour glucose had more than four times the risk of developing diabetes and significantly higher risks of cardiovascular death, cardiovascular events, and microvascular disease compared with those whose 1-hour readings were normal.10PubMed. Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study This has prompted calls to formally incorporate the 1-hour mark into diagnostic guidelines. For now, many clinical labs still only report fasting and 2-hour values, so if you want the 1-hour number, you may need to ask your provider to order the additional draw explicitly.
What the Shape of the Curve Tells You
Beyond the individual time-point numbers, the overall shape of the glucose curve during an OGTT carries its own information. Researchers have classified these shapes into broad categories. A “biphasic” curve rises after the glucose load, dips, and then rises slightly again before falling. A “monophasic” curve rises to a single peak and returns. A “continuously rising” curve never really comes back down during the test window.
Even when two people have identical fasting and 2-hour glucose levels, a monophasic curve is associated with lower insulin sensitivity and poorer pancreatic beta-cell function compared with a biphasic curve. This has been demonstrated in obese youth, where the monophasic group showed worse metabolic markers across the board despite matching the biphasic group on the values typically used for diagnosis.11PubMed Central. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth Adults with early type 2 diabetes show a similar pattern: biphasic responders tend to have better insulin and C-peptide responses to glucose, while those with a continuously rising curve have the weakest late-phase insulin response.12Diabetes Care. Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin In general, greater complexity in the curve shape, meaning more oscillations, is associated with better glucose tolerance.13PubMed. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?
Curve-shape analysis has not yet made it into routine clinical practice because it requires multiple blood draws (at least four or five time points) and there is no consensus on classification criteria. But as researchers push to extract more value from the OGTT, the shape of the response is emerging as a dimension that fasting glucose and HbA1c simply cannot capture.
Preparation Matters More Than Most People Realize
One underappreciated source of error in the OGTT is what you eat in the days before the test. The standard protocol calls for at least 150 grams of carbohydrates per day for the three days leading up to the test, with the last evening meal before the overnight fast containing at least 50 grams of carbohydrates. The WHO further recommends fasting 10 to 16 hours before the test, during which water is fine but nothing else.14PubMed Central. Carbohydrate Intake Prior to Oral Glucose Tolerance Testing
This is not a minor technicality. When someone following a low-carbohydrate diet takes the OGTT without adjusting their carb intake beforehand, their body can produce an exaggerated glucose spike simply because the metabolic machinery for processing carbs has been downregulated. Case reports and older literature confirm that skipping the carbohydrate-loading phase can produce false-positive results, leading to unnecessary alarm and potentially a misdiagnosis of diabetes.15PubMed Central. Carbohydrate Intake Prior to Oral Glucose Tolerance Testing In an era where low-carb and ketogenic diets are popular, this is a practical concern that clinicians do not always communicate clearly. Caffeine, smoking, and exercise on the morning of the test can also interfere with results. If your provider does not give you explicit prep instructions, ask.
The Reproducibility Problem
Even with perfect preparation, the OGTT has a well-documented reproducibility issue. If you take the same person and run the test twice under identical conditions, the 2-hour glucose value can vary substantially from one sitting to the next. In a large population-based study, the test-retest variability for the 2-hour glucose value was about 46% of the average reading in people with normal tolerance.16PubMed. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study Fasting glucose, by contrast, varied by only about 15%. In an elderly population, the coefficient of variation for the 2-hour value ranged from 12 to 18%.17PubMed. Intra- and interindividual variability of glucose tolerance in an elderly population
The practical consequence is real. In a study of overweight children who took the OGTT twice, only 30% of those classified as having impaired glucose tolerance on the first test still had that classification on the second.18The Journal of Clinical Endocrinology & Metabolism. Reproducibility of the Oral Glucose Tolerance Test in Overweight Children This does not mean the test is useless, but it does mean that a single borderline result should not be treated as definitive. If your 2-hour value lands near a diagnostic cutoff, a repeat test or complementary measures like HbA1c can provide a more complete picture. The variability is mostly biological rather than analytical: your body simply does not handle a sugar load with the same precision every time, affected by stress, sleep quality, hydration, and subtle hormonal fluctuations.
Gestational Diabetes Screening
The OGTT is the backbone of gestational diabetes screening, but how it gets used varies by country and medical organization. In the United States, the most common approach is a two-step process: first, a 50-gram glucose challenge at 24 to 28 weeks of pregnancy that does not require fasting, followed by a diagnostic 100-gram, 3-hour OGTT only if the first screen exceeds a threshold. Two or more elevated values on the second test are needed for a diagnosis. About 15 to 20% of screened women end up needing that second test.19PubMed. One-step or 2-step testing for gestational diabetes: which is better?
The alternative, recommended by the International Association of Diabetes and Pregnancy Study Groups and used widely outside the U.S., is a one-step approach: a single 75-gram, 2-hour OGTT that requires fasting, with just one elevated value sufficient for diagnosis. The one-step method identifies roughly 18 to 20% of pregnant women as having gestational diabetes, about two to three times the rate of the two-step method.20PubMed. One-step or 2-step testing for gestational diabetes: which is better?
Whether diagnosing more women actually improves outcomes is debated. A systematic review and meta-analysis of randomized trials found that one-step testing did not reduce the rate of large-for-gestational-age infants compared with two-step testing, but it did lead to more women being treated with diabetes medications and to modestly higher rates of neonatal hypoglycemia and NICU admissions.21PubMed Central. One- Compared to Two-Step Gestational Diabetes Screening and Pregnancy Outcomes: A Systematic Review and Meta-analysis The question of whether the additional diagnoses represent genuine disease or overdiagnosis is one of the more contentious areas in obstetric medicine right now.
The OGTT in PCOS
Polycystic ovary syndrome is one of the settings where the OGTT gets ordered outside of standard diabetes screening. Women with PCOS have a higher baseline risk for insulin resistance and type 2 diabetes, and professional guidelines generally recommend glucose screening. But the evidence suggests this risk is not equally distributed across all women with PCOS. In a study of lean, young women with the syndrome, only about 3% had impaired glucose tolerance by OGTT, and none were flagged by fasting glucose alone.22PubMed Central. Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome
A European review concluded that the OGTT should be used in women with PCOS in the same situations it would be indicated for anyone at elevated risk of type 2 diabetes: obesity, a history of gestational diabetes, or other metabolic risk factors. In lean women without those additional risk factors, routine OGTT may not be necessary.23European Journal of Endocrinology. Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT? Interestingly, the 1-hour glucose value during the OGTT shows promise as a tool for identifying insulin resistance in women with PCOS specifically, with one study proposing a cutoff of about 139 mg/dL at the 1-hour mark.24Clinical and Experimental Obstetrics & Gynecology. Optimal Cutoff Value of 1-Hour Postload Glucose to Identify Insulin Resistance in Women with Polycystic Ovary Syndrome
Uses Beyond Diabetes
The OGTT is not only a diabetes test. It also plays a diagnostic role in acromegaly, a condition caused by excess growth hormone. The test is used because growth hormone is normally suppressed when blood sugar rises. If growth hormone fails to drop below a certain threshold after a glucose load, that supports the diagnosis.25European Journal of Endocrinology. EP1190 – ECE_3870 – Paradoxical IGF-1 and GH elevation: diagnostic challenges beyond acromegaly
At the opposite end of the glucose spectrum, the OGTT can reveal reactive hypoglycemia, where blood sugar crashes excessively after an initial spike. This is sometimes seen after bariatric surgery. In one study of post-gastric-bypass patients, roughly two-thirds showed evidence of reactive hypoglycemia one to two hours after the glucose load, with some experiencing drops so dramatic that their peak-to-trough glucose ratio exceeded 4 to 1.26PubMed. Abnormal glucose tolerance testing after gastric bypass In children and adolescents with severe obesity, the OGTT has found impaired glucose tolerance in about a quarter of those tested, including silent type 2 diabetes in a small percentage of obese teenagers whose fasting glucose gave no indication of a problem.27PubMed. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Lab Handling Can Quietly Change Your Diagnosis
A factor that rarely comes up in patient-facing discussions is what happens to the blood sample between your arm and the analyzer. Glucose continues to be consumed by red and white blood cells in the tube after it is drawn, a process called glycolysis. If the tube sits at room temperature for too long before being processed, the measured glucose level will be artificially low. One study estimated that if the fasting glucose results at their hospital were corrected for the expected glycolysis at room temperature, the diagnostic rate for gestational diabetes could nearly double, from about 18% to about 35%.28PubMed. Time and temperature affect glycolysis in blood samples regardless of fluoride-based preservatives: a potential underestimation of diabetes Even fluoride-containing tubes, which are specifically designed to inhibit glycolysis, do not stop it immediately. Prompt centrifugation or chilling of samples is essential for accurate results.29PubMed Central. Strict Preanalytical Oral Glucose Tolerance Test Blood Sample Handling Is Essential for Diagnosing Gestational Diabetes Mellitus
This means that two labs processing your blood with slightly different turnaround times could generate meaningfully different results, especially around diagnostic cutoffs. It is not something you can control as a patient, but it is worth knowing that a borderline result can be influenced by factors that have nothing to do with your metabolism.
Venous Versus Capillary Blood
Most formal OGTTs use venous blood drawn from a vein in the arm and analyzed in a central lab. But in resource-limited settings, some programs have explored whether capillary blood from a fingerstick could serve as a substitute. The two sample types are correlated but not identical. Capillary glucose values tend to run slightly higher than venous values, particularly after the glucose load, and the published WHO conversion factors between them do not always match real-world measurements.30PubMed. Comparability of venous and capillary glucose measurements in blood
With adjusted cutoffs, capillary sampling can perform reasonably well. A study of gestational diabetes screening found that corrected capillary thresholds achieved about 85% sensitivity and 95% specificity for diagnosing GDM.31PubMed Central. Comparison of Venous and Capillary Sampling in Oral Glucose Testing for the Diagnosis of Gestational Diabetes Mellitus: A Diagnostic Accuracy Cross-Sectional Study Using Accu-Chek Inform II Another feasibility study of self-administered OGTTs with capillary monitoring found strong correlation with venous results and excellent sensitivity for identifying prediabetes or diabetes.32BMJ Open Diabetes Research & Care. Self-administered oral glucose tolerance test with capillary glucose measurements for the screening of diabetes mellitus in high-risk adults: a feasibility study This raises the possibility that in the future, some version of the OGTT could be done at home with a point-of-care glucose meter, potentially making the test far more accessible in settings where a lab visit is a barrier.
Continuous Glucose Monitors as an Alternative
Continuous glucose monitors, the wearable sensors that track interstitial glucose around the clock, offer a very different window into blood sugar dynamics than a single two-hour lab visit. Whether CGMs could replace the OGTT for certain applications is an active research question. In the context of predicting progression to type 1 diabetes in people already known to be at risk, the best CGM-derived metrics performed comparably to the best OGTT metrics for identifying who would progress rapidly.33PubMed Central. Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis CGMs have the obvious advantage of capturing glucose patterns over days rather than a single snapshot, and they avoid the reproducibility issues inherent in a one-off test. Their limitation is that they measure interstitial glucose rather than plasma glucose, introduce their own calibration uncertainties, and have not yet been validated as a replacement for the OGTT in standard diagnostic guidelines. For now, the OGTT retains its role as the formal diagnostic reference, but CGM data is increasingly being used alongside it in research and clinical monitoring.
The Incretin Effect and What the OGTT Uniquely Reveals
One reason the OGTT cannot be perfectly mimicked by intravenous glucose is the incretin effect: the gut amplifies insulin secretion in response to oral nutrients in a way that does not happen when the same amount of glucose is delivered directly into the bloodstream. The size of this effect is calculated by comparing insulin responses between an OGTT and a matched intravenous glucose infusion designed to produce identical blood sugar levels.34PubMed Central. Simulation of oral glucose tolerance tests and the corresponding isoglycemic intravenous glucose infusion studies for calculation of the incretin effect In healthy people, incretins account for a substantial share of the total insulin released after eating. In people with impaired glucose tolerance, the early GLP-1 response to oral glucose is blunted, and this may directly contribute to the sluggish early insulin release that defines their condition.35PubMed. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance This gut-mediated dimension of glucose metabolism is invisible to fasting blood tests and HbA1c alike, which is part of why the OGTT continues to have a clinical niche even as simpler tests become more widely used.